Germany / Switzerland / Italy / Austria / United States / /
Currency
pence / USD / / /
Event
FDA Phase / Product Issues / /
Facility
INSIG-SREBP complex / Howard Hughes Medical Institute / Dana-Farber Cancer Institute / University of Geneva / Laboratory of Lipid Metabolism / Hogenesch laboratory / University of Cambridge / University of Texas Southwestern Medical Center / REV-ERBa laboratory of Andrew Thomas Look / University of Bari / Medical University of Graz / Laboratory Animals / SCAP-SREBP complex / University of California / /
Harvard Medical School / University of Texas Southwestern Medical Center / Dallas / Period / Department of Internal Medicine / Austrian Science Foundation / SREBP / Italian Association for Cancer Research / Swiss National Foundation / Laboratory of Lipid Metabolism and Cancer / National Academy of Sciences / Dana-Farber Cancer Institute / Laboratory of Experimental and Molecular Hepatology / University of Bari / Louis Jeantet Foundation of Medicine / Department of Molecular Biology / Medical University of Graz / University of Cambridge / National Center of Competence / US Federal Reserve / International Human Frontier Science Program Organization / Federation of European Biochemical Societies / University of Geneva / Geneva / University of California at San Francisco / Howard Hughes Medical Institute / Ministry of Health / /
Person
David J. Mangelsdorf / Andrew Thomas Look / Thierry Claudel / Harlan Teklad / Antonio J. Vidal-Puig / Mario Negri Sud / Giuseppe Lo / /
Position
original author / using Q-RT / RT / player / Author / Academic Editor / Major / RT / reverse transcriptase; SCAP / reporter / /
REV-ERBa Participates in Circadian SREBP Signaling and Bile Acid Homeostasis Gwendal Le Martelot1, Thierry Claudel2, David Gatfield1, Olivier Schaad1, Benoıˆt Kornmann1¤, Giuseppe Lo Sasso3, Antonio Moschetta3, Ueli S